Impaired placentation in women with chronic hypertension who develop pre‐eclampsia
- 3 October 2017
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 50 (4) , 496-500
Abstract
Objective: To compare the degree of impaired placentation in women with and those without chronic hypertension (CH) who develop pre‐eclampsia (PE) in pregnancy.Methods: Data were derived from prospective screening for adverse pregnancy outcomes in women with singleton pregnancy attending their first routine hospital visit at 11 + 0 to 13 + 6 weeks' gestation. This visit included recording of maternal characteristics and medical history and measurement of mean arterial pressure (MAP), uterine artery pulsatility index (UtA‐PI), serum placental growth factor (PlGF) and serum pregnancy‐associated plasma protein‐A (PAPP‐A). The measured biomarkers were converted to multiples of the median (MoM) after adjustment for pregnancy characteristics. MoM values in women with CH who developed PE (n = 283) were compared to those of women without CH who developed PE (n = 2236).Results: In both groups with and without CH, measurements of MAP and UtA‐PI were increased, whereas those of PlGF and PAPP‐A were decreased and the deviation from normal in all biomarkers decreased with advancing gestational age at delivery with PE. There was no significant difference between women with and those without CH in the slope of the regression line of log10 MoM biomarker values against gestational age at delivery with PE for any of the biomarkers. However, there was a significant difference in the intercepts and coefficients of biomarkers in the two groups; compared to those without CH, MAP MoM, PlGF MoM and PAPP‐A MoM were higher and UtA‐PI MoM was lower in the CH group (all P < 0.01).Conclusion: In pregnancies that develop PE, the degree of impaired placentation, reflected in high UtA‐PI and low PlGF and PAPP‐A at 11–13 weeks' gestation, is less in women with CH than in those without CH. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.Keywords
Funding Information
- Fetal Medicine Foundation ((Charity No: 1037116))
This publication has 38 references indexed in Scilit:
- The “Great Obstetrical Syndromes” are associated with disorders of deep placentationAmerican Journal of Obstetrics and Gynecology, 2011
- Inflammation, Immunity, and HypertensionHypertension, 2011
- Maternal Plasma P-selectin at 11 to 13 Weeks of Gestation in Hypertensive Disorders of PregnancyHypertension in Pregnancy, 2010
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- First‐trimester maternal serum matrix metalloproteinase‐9 (MMP‐9) and adverse pregnancy outcomePrenatal Diagnosis, 2009
- Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsiaUltrasound in Obstetrics & Gynecology, 2008
- Mean Arterial Pressure at 11 +0 to 13 +6 Weeks in the Prediction of PreeclampsiaHypertension, 2008
- The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertension in Pregnancy, 2001
- Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsisAmerican Journal of Obstetrics and Gynecology, 1998
- A Non-Parametric Test of Whether Two Simple Regression Lines are ParallelThe Annals of Statistics, 1974